Since MTOR is a major regulator of cell metabolism, we were interested in the metabolic changes after genetic knockdown or pharmacological inhibition of MTOR and upstream pathways in B-ALL cells. The gene discussed is MTOR; the disease is precursor B-cell acute lymphoblastic leukemia.